Most recently, we developed second-generation thiazolyl ketone inhibitors of GIVA cPLA2, and we demonstrated that inhibition of GIVA cPLA2 causes oxidative stress-dependent cell death in acute leukemia cells [22]. This evidence concerns the gene PLA2G4A and acute leukemia.